• Haoxi Health Technology will hold an extraordinary general meeting in Beijing on June 2, 2026.
• Shareholders will vote on a sharp increase in authorized share capital to USD 35.2 trillion, comprising 100,000,000,000,000 Class A ordinary shares and 10,000,000,000,000 Class B ordinary shares.
• The meeting will also consider adopting amended and restated constitutional documents to reflect the share capital increase, including a change to the quorum definition.
• Another proposal seeks board authority to carry out one or more share consolidations within a cumulative range of 1-for-2 to 1-for-8,000, with any resulting fractional entitlements rounded up to whole shares.
• A separate item would allow the meeting to be adjourned to solicit additional votes if needed to pass the proposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-060088), on May 21, 2026, and is solely responsible for the information contained therein.